JORMA KESKI-OJA Two types of transforming growth factors (TGF) have been purified and well characterized, TGFa and TGFP. TGFa is a 5.6 kD single chain molecule that shows sequence homology to epidermal growth factor (EGF), binds to the EGF receptor, and has biological effects very similar to those o
Transforming growth factor β: Possible roles in the regulation of normal and leukemic hematopoietic cell growth
✍ Scribed by Jonathan R. Keller; Garwin K. Sing; Larry R. Ellingsworth; Francis W. Ruscetti
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 610 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
We have recently demonstrated that transforming growth factor (TGF)-Pl and TGF-02 are potent inhibitors of the growth and differentiation of murine and human hematopoietic cells. The proliferation of primary unfractionated murine bone marrow by interleukin-3 (IL-3) and human bone marrow by IL-3 or granulocyte/macrophage colony-stimulating factor (GM-CSF) was inhibited by TGF-01 and TGF-02, while the proliferation of murine bone marrow by GM-CSF or murine and human marrow with G-CSF was not inhibited. Mouse and human hematopoietic colony formation was differentially affected by TGF-@1 . In particular, CFU-GM, CFU-GEMM, BFU-E, and HPP-CFC, the most immature colonies, were inhibited by TGF-01, whereas the more differentiated unipotent CFU-G, CFU-M, and CFU-E were not affected. TGF-01 inhibited IL-3-induced growth of murine leukemic cell lines within 24 h, after which the cells were still viable. Subsequent removal of the TGF-01 results in the resumption of normal growth. TGF-01 inhibited the growth of factor-dependent NFS-60 cells in a dose-dependent manner in response to IL-3, GM-CSF, G-CSF, CSF-1, IL-4, or IL-6. TGF-01 inhibited the growth of a variety of murine and human myeloid leukemias, while erythroid and macrophage leukemias were insensitive. Lymphoid leukemias, whose normal cellular counterparts were markedly inhibited by TGF-0, were also resistant to TGF-P1 inhibition. These leukemic cells have no detectable TGF-01 receptors on their cell surface. Last, TGF-01 directly inhibited the growth of isolated Thy-1-positive progenitor cells. Thus, TGF-0 may be an important modulator of normal and leukemic hematopoietic cell growth.
📜 SIMILAR VOLUMES
The present study was conducted to determine the role of two autocrine factors, activin A and transforming growth factor beta (TGF-beta), in the growth regulation of AML12 hepatocytes. We overexpressed truncated type II activin and/or TGF-beta receptors in AML12 cells. In AML12 cells overexpressing
The effect of transforming growth factor-type f3 l(TGF-P) on the growth and differentiation of normal human skin keratinocytes cultured in serum-free medium was investigated. TCF-P markedly inhibited the growth of keratinocytes at the concentrations >2 ng/ml under low Ca2+ conditions (0.1 mM). Growt
Retinoic acid (RA) induces the activation of latent transforming growth factor-b (TGF-b) in bovine aortic endothelial cells (BAECs) via enhancement of cellular plasminogen activator (PA)/plasmin levels. The resultant TGF-b suppresses the excessive fibrinolytic activity by decreasing PA expression an
The actions of transforming growth factor , 8 (TGFP) and erythropoietin (Epo) were studied using normal erythroid progenitors from fetal rat liver and spleen at 18, 19 and 20 days. rhTGFbl inhibited the growth of late BFUe colonies significantly at each age and in both organs in methylcellulose cult
Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality worldwide. CD133, a transmembrane glycoprotein, is an important cell surface marker for both stem cells and cancer stem cells in various tissues including liver. CD133 expression has been recently linked to poor prognosis